Morely Health Communications

Juliet MorleyJuliet Morley, Director
I have 20 years of consultancy experience developing and implementing global and UK healthcare communications campaigns for pharmaceutical companies and charities. My experience spans public relations, medical education and clinical trials recruitment and retention support.

Click on the section that interests you:

My strengths include new business researching, programming and pitching, client and opinion leader relationship building, developing content and materials for meetings, facilitating creative brainstorms/meetings, writing for healthcare professional and patient/caregiver audiences and media sell ins. Fluency in French and Spanish helps me understand cultural nuances and build these needs into international programmes. I motivate my team members through my passion for health communications, my creative drive and energy, my coaching style and excellent leadership skills.

My consultancy experience includes:

Morley Health Communications: March 2008-Date

Ogilvy Healthworld: September 2003-March 2008
Associate Director, Fast4wD Ogilvy (clinical trials recruitment and retention support programmes)
Senior Director, Ogilvy 4D Communications (medical education)

Chandler Chicco Agency: August 2001-September 2003
Team Leader (healthcare public relations)

Hill and Knowlton: March 1998-June 2001
Account Director to Associate Director (healthcare public relations)

Complete Pharma PR (CPR): April 1994 –February 1998
Team Coordinator (healthcare public relations)

Recent Assignments:

  • GlaxoSmithKline: UK campaign to educate girls and women about cervical cancer.
  • Shire Pharmaceuticals: UK communications programme on Attention Deficit Hyperactivity Disorder

Key client and therapy area experience:

  • AstraZeneca: oncology global clinical trial recruitment and retention support programme
  • Lilly: mental health global clinical trial recruitment and retention support programme
  • AstraZeneca: oncology medical education programme (included oncology nurse meeting)
  • AstraZeneca: breast cancer communications programme
  • Pfizer: urology medical education programme (included distance learning programme for Continence Advisers)
  • Eli Lilly: mental health pre-launch medical education programme
  • GlaxoSmithKline: type 2 diabetes pre and post launch communications programme
  • Merck, Sharpe & Dohme: lipid-lowering communications programme
  • Merck Serono: global oncology clinical trials recruitment and retention programmes
  • Novartis: global dermatology communications programme
  • Roche Products Ltd: post-launch disease and brand awareness programme for an anti-obesity treatment targeted at policy makers, healthcare professionals and consumers. Ongoing issues management programme.